DEA's Drug Lab Shopping Watchlist: Chem Sellers Beware!
Published Date: 6/4/2025
Notice
Summary
The DEA just updated a special list of chemicals and equipment that can be used to make illegal drugs. If you sell these lab supplies without checking how they’ll be used, you could face fines. This update affects sellers and buyers, so watch for new rules and stay on the right side of the law!
Analyzed Economic Effects
2 provisions identified: 0 benefits, 2 costs, 0 mixed.
Civil Penalties for Reckless Distributions
If you sell lab supplies, you can face civil penalties if you distribute a laboratory supply to someone who uses or attempts to use it to make a controlled substance or listed chemical and the distribution was made with reckless disregard for that illegal use.
Updated Special Surveillance List Coverage
The Drug Enforcement Administration published an update to the Special Surveillance List; any chemical, product, material, or equipment on that list is defined as a "laboratory supply" under the Controlled Substances Act.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526 — Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128 — Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-11572 — Ashley Vermillion, N.P.; Decision and Order
Ashley Vermillion, a nurse practitioner from Maine, lost her DEA registration because she no longer has the legal right to handle controlled substances in her state. She didn’t ask for a hearing, so the DEA moved forward and officially revoked her registration. This means she can’t prescribe or manage controlled drugs anymore, effective immediately.
2026-11416 — Importer of Controlled Substances Application: CalCog Inc.
CalCog Inc. wants to become an official importer of some powerful controlled substances like LSD and 5-MeO-DMT. People and companies involved with these drugs have until July 8, 2026, to share their thoughts or ask for a hearing. This move could shake up the import scene, but no costs or changes happen until the DEA decides.
2026-10380 — Schedules of Controlled Substances: Placement of Diphenidine in Schedule I
The DEA wants to put diphenidine, a drug, into Schedule I, which means it will be treated like the most tightly controlled substances. This change affects anyone who makes, sells, studies, or owns diphenidine, adding strict rules and penalties. You’ve got until June 25, 2026, to share your thoughts before the new rules might kick in.
2026-10253 — Schedules of Controlled Substances: Temporary Placement of 2-Fluorodeschloroketamine in Schedule I
Starting May 22, 2026, the DEA is putting 2-fluorodeschloroketamine (2-FDCK) into Schedule I, meaning it’s now treated like the most dangerous drugs. This affects anyone who makes, sells, or uses it, adding strict rules and serious penalties. The temporary ban lasts two years, giving the government time to decide if it should stay permanent.
Previous / Next Documents
Previous: 2025-10086 — Notice of Public Meetings of the Colorado Advisory Committee to the U.S. Commission on Civil Rights
The Colorado Advisory Committee will hold two virtual meetings on June 18 and July 8, 2025, to plan discussions about antisemitism on three Denver college campuses. Students, staff, and community members connected to these schools might see new efforts to understand and address this issue. These meetings are free to join and aim to make campuses safer and more welcoming.
Next: 2025-10088 — Idaho Panhandle Resource Advisory Committee
The Idaho Panhandle Resource Advisory Committee is holding public meetings to help decide on projects and funding for local forests in five counties. They also review recreation fees for these forest sites. If you live or play in these areas, your input could shape how the forests are cared for and how much you might pay to enjoy them.